Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder.

Harris E, Eng HY, Kowatch R, Delgado SV, SaldaƱa SN.

J Child Adolesc Psychopharmacol. 2010 Aug;20(4):347-53. doi: 10.1089/cap.2009.0126.

PMID:
20807074
2.

Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.

Andrade C.

J Clin Psychiatry. 2012 Nov;73(11):e1362-4. doi: 10.4088/JCP.12f08200. No abstract available.

3.
4.

Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.

Apter A, Ratzoni G, King RA, Weizman A, Iancu I, Binder M, Riddle MA.

J Am Acad Child Adolesc Psychiatry. 1994 Mar-Apr;33(3):342-8.

PMID:
8169178
5.

Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Figgitt DP, McClellan KJ.

Drugs. 2000 Oct;60(4):925-54. Review.

PMID:
11085201
6.

[Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].

Baving L, Schmidt MH.

Z Kinder Jugendpsychiatr Psychother. 2000 Feb;28(1):35-44. German.

PMID:
10746297
7.

Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.

Goodman WK, Kozak MJ, Liebowitz M, White KL.

Int Clin Psychopharmacol. 1996 Mar;11(1):21-9.

PMID:
8732310
8.

Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder.

Dell'Osso B, Allen A, Hollander E.

Expert Opin Pharmacother. 2005 Dec;6(15):2727-40. Review.

PMID:
16316311
9.

Serotonin syndrome and fluvoxamine: a case study.

Bastani JB, Troester MM, Bastani AJ.

Nebr Med J. 1996 Apr;81(4):107-9.

PMID:
8628448
10.

The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.

McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.

J Clin Psychopharmacol. 1993 Oct;13(5):354-8.

PMID:
8227493
11.

Photosensitivity reaction associated with selective serotonin re-uptake inhibitors: possible cross-sensitivity?

Cheng YC, Huang MC.

Psychiatry Clin Neurosci. 2014 Mar;68(3):244. No abstract available.

PMID:
24895743
12.

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.

J Clin Psychiatry. 2003 Jun;64(6):640-7.

PMID:
12823077
13.

Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

Goodman WK, Ward H, Kablinger A, Murphy T.

J Clin Psychiatry. 1997;58 Suppl 5:32-49. Review.

14.

Ecchymoses as an adverse effect of fluvoxamine treatment in an adolescent girl.

Vlatka BM, Branka AM, Branimir M.

Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):e9-e10. doi: 10.1016/j.genhosppsych.2010.01.005. Epub 2010 Feb 1. No abstract available.

PMID:
20633737
16.
17.

Extended-release fluvoxamine (Luvox CR).

[No authors listed]

Med Lett Drugs Ther. 2008 Jun 30;50(1289):50-1. No abstract available.

PMID:
18583947
18.

Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.

[No authors listed]

Prescrire Int. 2004 Oct;13(73):163-5.

PMID:
15499694
19.

Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.

Pratheesh PJ, Praharaj SK, Srivastava A.

Psychopharmacol Bull. 2011;44(1):70-3.

20.

Supplemental Content

Support Center